# Sugammadex

## Bridion inj 200mg/2mL

| TAH Drug Code      | [IBRID](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBRID)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Used in adults as a reversal agent for neuromuscular blockade induced by rocuronium or vecuronium. Used in children and adolescents as a routine reversal agent for neuromuscular blockade induced by rocuronium or vecuronium.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Routine reversal of rocuronium- or vecuronium-induced blockade: IV: Deep block (at least 1 to 2 post-tetanic counts but prior to appearance of T2): 4 mg/kg as a single dose Moderate block (after appearance of T2): 2 mg/kg as a single dose Readministration of rocuronium or vecuronium: Following sugammadex use for routine reversal, waiting times for readministration of rocuronium or vecuronium vary greatly (5 minutes to 24 hours) depending on agent, dose, and renal function; if immediate neuromuscular blockade is needed, a nonsteroidal neuromuscular-blocking agent may be required. Immediate reversal of rocuronium-induced blockade: IV: 16 mg/kg as a single dose administered soon (~3 minutes) after administration of a single dose of rocuronium 1.2 mg/kg. Note: This dose of sugammadex has not been evaluated following administration of vecuronium.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to sugammadex or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | >10%: Cardiovascular: Hypotension (5% to 13%) Gastrointestinal: Nausea (adults: 26%; children, adolescents: 2% to 6%), vomiting (neonates, infants, children, adolescents, adults: 2% to 15%) Nervous system: Pain (48% to 59%) 1% to 10%: Cardiovascular: Bradycardia (children, adolescents, adults: 5% to 10%), ECG abnormality (6%; including prolonged QT interval on ECG), hypertension (9%), tachycardia (2% to 5%) Dermatologic: Erythema of skin (2%), pruritus (3%) Endocrine & metabolic: Hypocalcemia (2%) Gastrointestinal: Abdominal pain (4% to 6%), flatulence (3%), xerostomia (<=2%) Hematologic & oncologic: Decreased red blood cells (1% to 2%) Hypersensitivity: Hypersensitivity reaction (7% to 9%; including severe hypersensitivity reaction; anaphylaxis [<1%]) Nervous system: Anxiety (1% to 3%), chills (7%), depression (<=2%), dizziness (3% to 6%), headache (10%), hypoesthesia (3%), insomnia (5%), restlessness (1% to 2%) Neuromuscular & skeletal: Increased creatine phosphokinase in blood specimen (1% to 2%), limb pain (6%), musculoskeletal pain (2%), myalgia (2%) Ophthalmic: Ophthalmic signs and symptoms (children, adolescents: 1% to 6%) Respiratory: Cough (3% to 8%) Miscellaneous: Fever (neonates, infants, children, adults: 5% to 9%) Frequency not defined: Hematologic & oncologic: Increased INR, prolonged partial thromboplastin time, prolonged prothrombin time Postmarketing: Cardiovascular: Atrial fibrillation, atrioventricular block, ST segment changes on ECG, supraventricular extrasystole, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia Hypersensitivity: Anaphylactic shock, nonimmune anaphylaxis, type I hypersensitivity reaction Neuromuscular & skeletal: Laryngospasm Respiratory: Bronchospasm (Ruetzler 2022), dyspnea, pulmonary edema, wheezing |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sugammadex-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

